Technical Analysis for NGEN - Nervgen Pharma Corp
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 2.110 | 4.46% | 0.090 |
NGEN closed up 4.46 percent on Friday, April 26, 2024, on 79 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: May 13
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| 20 DMA Resistance | Bearish | 4.46% | |
| 20 DMA Resistance | Bearish | 0.96% | |
| 200 DMA Resistance | Bearish | 0.96% | |
| Pocket Pivot | Bullish Swing Setup | 0.96% | |
| 20 DMA Resistance | Bearish | 2.43% | |
| 200 DMA Resistance | Bearish | 2.43% | |
| Fell Below 20 DMA | Bearish | -0.94% | |
| Fell Below 200 DMA | Bearish | -0.94% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | about 18 hours ago |
| Rose Above 20 DMA | about 18 hours ago |
| Up 5% | about 18 hours ago |
| Possible NR7 | about 18 hours ago |
| Rose Above 10 DMA | about 22 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 2024-05-13
NervGen Pharma Corp. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of nerve damage. Its product candidate is the NVG-291 that is in clinical studies for the treatment of spinal cord injuries (SCI). It has a licensing agreement with Case Western Reserve University of Cleveland, Ohio to research, develop, and commercialize a patented technology with therapeutic potential for SCI and other conditions associated with nerve damage. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Pharma Pharmaceutical Clinic Pharmaceutical Products
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Pharma Pharmaceutical Clinic Pharmaceutical Products
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 3.98 |
| 52 Week Low | 1.5 |
| Average Volume | 105,205 |
| 200-Day Moving Average | 2.212 |
| 50-Day Moving Average | 2.611 |
| 20-Day Moving Average | 2.138 |
| 10-Day Moving Average | 2.072 |
| Average True Range | 0.159 |
| RSI (14) | 43.50 |
| ADX | 39.15 |
| +DI | 12.575 |
| -DI | 26.916 |
| Chandelier Exit (Long, 3 ATRs) | 1.864 |
| Chandelier Exit (Short, 3 ATRs) | 2.346 |
| Upper Bollinger Bands | 2.330 |
| Lower Bollinger Band | 1.945 |
| Percent B (%b) | 0.43 |
| BandWidth | 18.040 |
| MACD Line | -0.128 |
| MACD Signal Line | -0.156 |
| MACD Histogram | 0.028 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.290 | ||||
| Resistance 3 (R3) | 2.287 | 2.223 | 2.260 | ||
| Resistance 2 (R2) | 2.223 | 2.177 | 2.225 | 2.250 | |
| Resistance 1 (R1) | 2.167 | 2.149 | 2.195 | 2.170 | 2.240 |
| Pivot Point | 2.103 | 2.103 | 2.118 | 2.105 | 2.103 |
| Support 1 (S1) | 2.047 | 2.057 | 2.075 | 2.050 | 1.980 |
| Support 2 (S2) | 1.983 | 2.029 | 1.985 | 1.970 | |
| Support 3 (S3) | 1.927 | 1.983 | 1.960 | ||
| Support 4 (S4) | 1.930 |
